Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Expect Adoption of HCV Testing Guidelines

June 8, 2012 8:45 AM EDT Send to a Friend
Canaccord Genuity reiterates a 'Buy' on OraSure Technologies (NASDAQ: OSUR) price target of $14.00.

Analyst, Jeffrey Frelick, said, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login